Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-021902
Filing Date
2017-03-21
Accepted
2017-03-21 08:34:14
Documents
1
Period of Report
2017-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5430
  Complete submission text file 0001209191-17-021902.txt   6828
Mailing Address C/O AEGERION PHARMACEUTICALS 89 HEADQUARTERS PLAZA, SUITE 1212 MORRISTOWN NJ 07960
Business Address
Beer Marc D (Reporting) CIK: 0001314575 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36517 | Film No.: 17703063

Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Issuer) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations